IASTM Versus PRT in Patients With Chronic PF

Sponsor
Cairo University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05754697
Collaborator
(none)
60
3
3.5

Study Details

Study Description

Brief Summary

The goal of this clinical trial] is to compare between the effect of instrument assisted soft tissue mobilization and positional release technique in patients with chronic plantar fasciitis

The main question[s] it aims to answer are:
  1. Is there a difference between the effect of instrument assisted soft tissue mobilization and positional release technique on pain pressure threshold in patients with chronic plantar fasciitis?

  2. Is there a difference between the effect of instrument assisted soft tissue mobilization and positional release technique on foot function level in patients with chronic plantar fasciitis?

Condition or Disease Intervention/Treatment Phase
  • Other: Instrument assisted soft tissue mobilization in addition to traditional treatment
  • Other: Positional release technique in addition to traditional treatment
  • Other: Traditional treatment
N/A

Detailed Description

Design of the study:

Pretest - posttest randomized controlled trial.

Subjects selection:

Sixty patients their age range from 30-50 years of both genders with chronic plantar fasciitis will participate in this study according to sample size calculation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Instrument Assisted Soft Tissue Mobilization Versus Positional Release Technique in Patients With Chronic Plantar Fasciitis
Anticipated Study Start Date :
Mar 15, 2023
Anticipated Primary Completion Date :
Jun 15, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: instrument assisted soft tissue mobilization in addition to traditional treatment

study group

Other: Instrument assisted soft tissue mobilization in addition to traditional treatment
The treatment protocol will be two sessions will be given per week for 4 weeks.

Experimental: positional release technique in addition to traditional treatment

study group

Other: Positional release technique in addition to traditional treatment
The treatment protocol will be two sessions will be given per week for 4 weeks.

Active Comparator: traditional treatment

control group

Other: Traditional treatment
The treatment protocol will be two sessions will be given per week for 4 weeks.

Outcome Measures

Primary Outcome Measures

  1. Pressure Algometer (Change in pain pressure threshold) [Pre-intervention and immediately after intervention]

    Change in pain pressure threshold as assessed using pressure algometer on medial plantar process, with the unit of measurement in kg/cm². Change in pain pressure threshold as assessed using pressure algometer on gastrocnemius muscle, with the unit of measurement in kg/cm². Change in pain pressure threshold as assessed using pressure algometer on soleus muscle, with the unit of measurement in kg/cm². Change in pain pressure threshold as assessed using pressure algometer over the posteromedial aspect of the calcaneus , with the unit of measurement in kg/cm².

Secondary Outcome Measures

  1. The Arabic Version of Foot and Ankle Ability Measure [Pre-intervention and immediately after intervention]

    The foot and ankle ability measure is a reliable, responsive, and valid measure of physical function for individuals with a broad range of musculoskeletal disorders of the lower leg, foot, and ankle. This self-report outcome instrument is available in English, German, French and Persian. The Foot and Ankle Ability Measure is a 29-item questionnaire divided into two subscales: the Foot and Ankle Ability Measure, 21-item Activities of Daily Living Subscale and the Foot and Ankle Ability Measure, 8-item Sports Subscale. Each item is scored on a 5-point Likert scale (4 to 0) from 'no difficulty at all' to 'unable to do'. Item score totals, which range from 0 to 84 for the ADL subscale and 0 to 32 for the Sports subscale, were transformed to percentage scores. Higher scores represent higher levels of function for each subscale, with 100% representing no dysfunction.

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Clinically diagnosed cases of plantar fasciitis not less than 3 months.

  2. Heel pain felt maximally over plantar aspect of heel.

  3. Pain in the heel on the first step in the morning.

  4. Their age ranging from 30-50 years.

  5. Body mass index range from (18.5 to 24.9 kg/m2).

Exclusion Criteria:
  1. Subjects can't tolerate close physical contact.

  2. Athletes.

  3. Subjects with skin infections.

  4. Subjects with recent fracture with incomplete bony union.

  5. Subjects with acute inflammatory or infectious process.

  6. Subjects with hematoma.

  7. Subjects with osteoporosis.

  8. Subjects with foot deformity.

  9. Subjects that take medications that may increase blood clotting.

  10. Surgery to the ankle or foot.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: Doaa Ibrahim, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Doaa Said Mohamed Ibrahim, Assistant Lecturer, Cairo University
ClinicalTrials.gov Identifier:
NCT05754697
Other Study ID Numbers:
  • P.T.REC/012/003841
First Posted:
Mar 6, 2023
Last Update Posted:
Mar 6, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Doaa Said Mohamed Ibrahim, Assistant Lecturer, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 6, 2023